{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T18:15:39Z","timestamp":1715969739694},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","respiratoryinvestigation.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.resinv.2013.07.002","type":"journal-article","created":{"date-parts":[[2013,9,13]],"date-time":"2013-09-13T16:45:34Z","timestamp":1379090734000},"page":"101-106","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comparison of cisplatin plus pemetrexed and cisplatin plus gemcitabine for the treatment of malignant pleural mesothelioma in Japanese patients"],"prefix":"10.1016","volume":"52","author":[{"given":"Takehito","family":"Shukuya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisao","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Tokito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Akamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuhiko","family":"Taira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotsugu","family":"Kenmotsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tateaki","family":"Naito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruyasu","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2013.07.002_bib1","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.resinv.2013.07.002_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1200\/JCO.1999.17.1.25","article-title":"Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study","volume":"17","author":"Byrne","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.resinv.2013.07.002_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/01.coc.0000144852.75613.56","article-title":"Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study","volume":"28","author":"Castagneto","year":"2005","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.resinv.2013.07.002_bib4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.lungcan.2007.09.018","article-title":"Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: a phase II study of the Southwest Oncology Group (SWOG 9810)","volume":"60","author":"Kalmadi","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1016\/j.resinv.2013.07.002_bib5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/sj.bjc.6600505","article-title":"A multicenter phase II study of cisplatin and gemcitabine for malignant mesothelioma","volume":"87","author":"Nowak","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.resinv.2013.07.002_bib6","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/sj.bjc.6600118","article-title":"Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma","volume":"86","author":"van Haarst","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.resinv.2013.07.002_bib7","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1200\/JCO.2007.15.0375","article-title":"Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-na\u00efve patients with advanced-stage non-small-cell lung cancer","volume":"26","author":"Scagliotti","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.resinv.2013.07.002_bib8","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/JTO.0b013e3181d1273d","article-title":"Efficacy and safety of cisplatin\/pemetrexed versus cisplatin\/gemcitabine as first-line treatment in East Asian patients with advanced non-small cell lung cancer. Results of an exploratory subgroup analysis of a phase III trial","volume":"5","author":"Yang","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.resinv.2013.07.002_bib9","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1158\/1078-0432.CCR-07-5143","article-title":"Efficacy and safety of two doses of pemetrexed supplemented with folic acid and vitamin B12 in previously treated patients with non-small cell lung cancer","volume":"14","author":"Ohe","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.resinv.2013.07.002_bib10","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1378\/chest.108.4.1122","article-title":"A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group","volume":"108","author":"Rusch","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2013.07.002_bib11","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1200\/JCO.2010.34.4614","article-title":"Antiemetics: American Society of Clinical Oncology clinical practice guideline update","volume":"29","author":"Basch","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.resinv.2013.07.002_bib12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors (RECIST Guidelines)","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.resinv.2013.07.002_bib13","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) v3.0. Bethesda, MD: Cancer Therapy Evaluation Program; August 9, 2006. \u3008http:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm\u3009."},{"key":"10.1016\/j.resinv.2013.07.002_bib14","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.lungcan.2008.09.008","article-title":"Outcomes with first-line platinum-based combination chemotherapy for malignant pleural mesothelioma: a review of practice in British Columbia","volume":"64","author":"Lee","year":"2009","journal-title":"Lung Cancer"},{"key":"10.1016\/j.resinv.2013.07.002_bib15","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/jjco\/hyq083","article-title":"The efficacy of the frontline platinum-based combination chemotherapy in malignant peritoneal mesothelioma","volume":"40","author":"Kim","year":"2010","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.resinv.2013.07.002_bib16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/jjco\/hyn024","article-title":"Efficacy and safety of pemetrexed in combination with cisplatin for malignant pleural mesothelioma: a phase I\/II study in Japanese patients","volume":"38","author":"Nakagawa","year":"2008","journal-title":"Jpn J Clin Oncol"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534513000907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534513000907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T23:30:03Z","timestamp":1539387003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534513000907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S2212534513000907"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2013.07.002","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of cisplatin plus pemetrexed and cisplatin plus gemcitabine for the treatment of malignant pleural mesothelioma in Japanese patients","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2013.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Japanese Respiratory Society. Published by Elsevier Japan KK All rights reserved.","name":"copyright","label":"Copyright"}]}}